Biomarin Pharmaceutical reported $29.33M in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -113016000 68.36M
Acorda Therapeutics ACOR:US $ -13503000 3.34M
Agios Pharmaceuticals AGIO:US $ -101145000 3.68M
Alnylam Pharmaceuticals ALNY:US $ -146732000 47.83M
Amgen AMGN:US $ 2500M 196M
Bayer BAYN:GR 4.17B 704M
Biogen BIIB:US $ 531.5M 11.7M
Biomarin Pharmaceutical BMRN:US $ 29.33M 95.21M
Bluebird Bio BLUE:US $ -120346000 138.95M
Gilead Sciences GILD:US $ 2897M 1957M
Insmed INSM:US $ -101451000 1.41M
Intercept Pharmaceuticals ICPT:US $ -10272000 10.59M
IONIS PHARMACEUT IONS:US $ -57504000 278.11M
Moderna Inc MRNA:US 4.23B 1.18B
Neurocrine Biosciences NBIX:US $ 3.1M 60.9M
Ptc Therapeutics PTCT:US $ -86522000 1.79M
Puma Biotechnology PBYI:US $ -747000 7.58M
Regeneron Pharmaceuticals REGN:US $ 1286.6M 1353.1M
Sangamo Biosciences SGMO:US $ -45261000 5.36M
Sarepta Therapeutics SRPT:US $ -86881000 18.93M
Seattle Genetics SGEN:US $ -133050000 39.02M
Ultragenyx Pharmaceutical RARE:US $ -136632000 34.07M
United Therapeutics UTHR:US $ 288M 117.2M
Vertex Pharmaceuticals VRTX:US $ 1033.4M 157.68M
YTE INCY:US $ 127.66M 7.71M